E. K. Alidjinou

发表

Persistent coxsackievirus B infection and pathogenesis of type 1 diabetes mellitus

D. Hober, E. Alidjinou, M. P. Nekoua, 2022, Nature Reviews Endocrinology.

Assay for Hepatitis B Core-related Antigen Identify Patients With High Viral Load: Systematic Review and Meta-analysis of Individual Participant Data.

M. Buti, M. Honda, Hwai I. Yang, 2020, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

RNA and DNA Sanger sequencing versus next-generation sequencing for HIV-1 drug resistance testing in treatment-naive patients

D. Hober, E. Alidjinou, P. Choisy, 2017, The Journal of antimicrobial chemotherapy.

Effect of Coxsackievirus B4 Infection on the Thymus: Elucidating Its Role in the Pathogenesis of Type 1 Diabetes

D. Hober, E. Alidjinou, V. Geenen, 2021, Microorganisms.

Viruses and Endocrine Diseases

D. Hober, E. Alidjinou, F. Sane, 2023, Microorganisms.

Clofoctol inhibits SARS-CoV-2 replication and reduces lung pathology in mice

J. Dubuisson, D. Hober, S. Belouzard, 2022, PLoS pathogens.

Endotheliopathy Is Induced by Plasma From Critically Ill Patients and Associated With Organ Failure in Severe COVID-19

R. Bordet, P. Lenting, S. Susen, 2020, Circulation.

Enteroviral Pathogenesis of Type 1 Diabetes: The Role of Natural Killer Cells

A. Yessoufou, K. Moutairou, D. Hober, 2020, Microorganisms.

Low Serum Levels of Interferon Alpha in COVID-19 Patients Are Associated with Older Age

D. Hober, E. Alidjinou, J. Poissy, 2022, Journal of clinical medicine.

Serum-dependent enhancement of coxsackievirus B4-induced production of IFNα, IL-6 and TNFα by peripheral blood mononuclear cells.

D. Hober, E. Alidjinou, I. Engelmann, 2013, Journal of molecular biology.

Persistence of Coxsackievirus B4 in Pancreatic β Cells Disturbs Insulin Maturation, Pattern of Cellular Proteins, and DNA Methylation

I. Fournier, D. Hober, E. Alidjinou, 2021, Microorganisms.

Persistence of Coxsackievirus B4 in pancreatic ductal-like cells results in cellular and viral changes

D. Hober, E. Alidjinou, C. Villenet, 2017, Virulence.

Infection à coxsackievirus B4, inflammation et persistance

E. Alidjinou, E. K. Alidjinou, 2016 .

Enterovirus persistence as a mechanism in the pathogenesis of type 1 diabetes.

D. Hober, E. Alidjinou, V. Geenen, 2014, Discovery medicine.

Persistent coxsackievirus B4 infection induces microRNA dysregulation in human pancreatic cells

D. Hober, E. Alidjinou, C. Villenet, 2017, Cellular and Molecular Life Sciences.

Comparison of two commercial quantitative PCR assays for EBV DNA detection and their correlation with the first WHO International Standard for EBV

A. Duhamel, D. Hober, E. Alidjinou, 2018, Journal of medical microbiology.

Comparison of two commercial quantitative PCR assays and correlation with the first WHO International Standard for human CMV.

E. Chazard, D. Hober, E. Alidjinou, 2018, Diagnostic microbiology and infectious disease.

Resistance of Enteric Viruses on Fomites

D. Hober, P. Lobert, E. Alidjinou, 2017, Intervirology.

SARS-CoV-2 detection using a nanobody-functionalized voltammetric device

R. Boukherroub, D. Devos, C. Cambillau, 2022, Communications Medicine.

Preanalytical Issues and Cycle Threshold Values in SARS-CoV-2 Real-Time RT-PCR Testing: Should Test Results Include These?

R. Boukherroub, D. Devos, C. Cambillau, 2021, ACS omega.

The promising efficacy of a risk-based letermovir use strategy in CMV-positive allogeneic hematopoietic cell recipients

I. Yakoub-Agha, K. Faure, E. Alidjinou, 2022, Blood advances.

Very slow decline of hepatitis B virus surface antigen and core related antigen in chronic hepatitis B patients successfully treated with nucleos(t)ide analogues

D. Hober, E. Alidjinou, V. Canva, 2018, Journal of medical virology.

Fluoxetine Can Inhibit SARS-CoV-2 In Vitro

J. Dubuisson, D. Hober, S. Belouzard, 2021, Microorganisms.

Emergence of Q493R mutation in SARS-CoV-2 spike protein during bamlanivimab/etesevimab treatment and resistance to viral clearance

D. Hober, E. Alidjinou, I. Engelmann, 2021, Journal of Infection.

Respiratory virus detection in returning travelers and pilgrims from the Middle East

D. Hober, K. Faure, E. Alidjinou, 2022, Travel medicine and infectious disease.

Combating coxsackievirus B infections

D. Hober, E. Alidjinou, F. Sane, 2022, Reviews in medical virology.

Fighting Enteroviral Infections to Prevent Type 1 Diabetes

D. Hober, E. Alidjinou, F. Sane, 2022, Microorganisms.

Rapid syndromic testing for respiratory viral infections in children attending the emergency department during COVID-19 pandemic in Lille, France, 2021–2022

D. Hober, E. Alidjinou, M. Lazrek, 2022, Journal of Clinical Virology.

Evaluation of a rapid semiquantitative lateral flow assay for the prediction of serum neutralizing activity against SARS-CoV-2 variants

D. Hober, K. Faure, E. Alidjinou, 2022, Journal of Clinical Virology.

A comparison of high-throughput SARS-CoV-2 sequencing methods from nasopharyngeal samples

A. Boland, J. Deleuze, C. Daviaud, 2022, Scientific Reports.

Sensitivity of SARS-CoV-2 variant Delta to serum neutralization in BNT162b2 vaccinees and unvaccinated COVID-19 recovered cases

D. Hober, K. Faure, E. Alidjinou, 2021, Infection.

Viruses and Type 1 Diabetes: Focus on the Enteroviruses

D. Hober, A. Goffard, E. Alidjinou, 2013 .

Antibodies enhance the infection of phorbol-ester-differentiated human monocyte-like cells with coxsackievirus B4.

D. Hober, P. Lobert, A. Goffard, 2013, Microbes and infection.

Antibody and T cell memory immune response after two doses of the BNT162b2 mRNA vaccine in older adults with and without prior SARS-CoV-2 infection

A. Duhamel, A. Dendooven, D. Deplanque, 2021, bioRxiv.

Severe SARS‐CoV‐2 patients develop a higher specific T‐cell response

S. Susen, A. Duhamel, A. Dendooven, 2020, Clinical & translational immunology.